HomeAdvocacy Advocacy News

Advocacy News

Displaying results 1-10 (of 196)
 |<  < 1 2 3 4 5 6 7 8 9 10  >  >| 

CMS Issues Final Rule Affecting Patient Access and Prescription Drug Affordability

The Centers for Medicare and Medicaid (CMS) published its “Medicare Advantage and Part D Drug Pricing Final Rule” in May which seeks to increase drug pricing transparency, lower prescription drug costs, and improve patient medication adherence.

READ MORE

CSRO President Testifies Before Congress

Last week, the House Energy and Commerce Subcommittee on Health held a hearing entitled: “Improving Drug Pricing Transparency and Lowering Prices for American Consumers.” CSRO President, Dr. Madelaine Feldman, was invited to represent the Alliance for Specialty Medicine and deliver testimony at the hearing.

READ MORE

FDA Releases Final Guidance on Interchangeable Biosimilars

Last week, the FDA released its long anticipated final guidance for industry on “Considerations in Demonstrating Interchangeability with a Reference Product.”

READ MORE

CSRO offers Federal Policy Virtual “Town Hall” to Rheumatology Community

The gridlock immobilizing Congress has slowed the progress of health care legislation significantly, but it has not stopped key Federal agencies from proposing and implementing policies that have a far reaching impact on the practice of rheumatology.

READ MORE

CSRO Comments on Proposed Rule to Eliminate Safe Harbor Protections for Prescription Drug Rebates

The Coalition of State Rheumatology Organizations (CSRO) recently submitted comments on the Department of Health and Human Services (HHS) proposed rule amending the Federal anti-kickback statute.

READ MORE

Wisconsin Step Therapy Reform a Coalition Effort

CSRO, in partnership with the Wisconsin Step Therapy Coalition is taking the lead on step therapy reform in the state.

READ MORE

CSRO’s Dr. Robert Levin Discusses Drug Pricing in the U.S.

CSRO Board Member, Robert Levin, participated in the Healthcare Policy podcast on February 18 to discuss federal prescription drug pricing reform. In his capacity as a practicing physician, and president the Alliance for Transparent and Affordable Prescriptions, Dr. Levin provided expert testimony on drug pricing reform proposals and how the drug supply chain works.

READ MORE

The CSRO Holds Fellows Conference with Record Attendance

On February 9, 2019, the CSRO held its annual Fellows Conference in San Francisco, complete with a number of presentations on topics that surround today’s Rheumatologist.

READ MORE

Indiana Demands Policy Against Forced Medication Switches

Non-medical switching is a strategy used by health plans to reduce expenses by switching the prescription for a stable patient to a “preferred” drug — for reasons unrelated to the patients’ well-being and in some cases without warning.

READ MORE

Illinois Non-Medical Switching Law in Effect

A new law in Illinois ensures that commercial health plans deliver on policies they market and sell to Illinoisans. Prior to January 1st of this year, insurers in Illinois could change prescription drug coverage on a patient at any point during the year, and while patients were still locked into their plan. This practice is referred to as “non-medical switching” and can have serious negative health effects for patients.

READ MORE

Displaying results 1-10 (of 196)
 |<  < 1 2 3 4 5 6 7 8 9 10  >  >|